Thomas E Gottwald sold $137k of NEU
Chairman, President & CEO at NEWMARKET CORP. 216 shares at an average of $632.00, traded Mar 6, 2024, filed Mar 8, 2024.
Score components
- +25RoleCEO
- +11Trade size$137k at market
- 0Share of holdings soldSold 0.1% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-028654, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 6, 2024 | SOpen-market sale Common Stock | -216 | $632.00 | $137k | 153,569 | Mar 8, 2024 |
Related signals
Other insiders at NEWMARKET CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | NEUbuy NEWMARKET CORP | Ting Xu director | $248k 400 shares | +76% | |
| 17Weak | NEWMARKET CORP | Bruce R Hazelgrove III EVP & CAO | $200k 311 shares | -46% | |
| 50Moderate | NEUsell NEWMARKET CORP | Thomas E Gottwald Chairman, President & CEO | $1.9M 3,000 shares | -2% | |
| 50Moderate | NEUsell NEWMARKET CORP | Thomas E Gottwald Chairman, President & CEO | $3.2M 4,884 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.